IMAGE

Fig. 2

ID
ZDB-IMAGE-190801-48
Source
Figures for Jiménez-Amilburu et al., 2019
Image
Figure Caption

Fig. 2

Crb2a localization in developing CMs is modulated by blood flow and Nrg2a/ErbB2 signaling. (A-B″) Crb2a immunostaining in Tg(myl7:ras-EGFP) control (A, n=8) and tnnt2a morphant (B, n=8) hearts at 80 hpf. Higher-magnification images show apical localization of Crb2a in control (A′,A″) and tnnt2a morphant hearts (B′,B″); arrowheads indicate junctional localization of Crb2a between CMs. (C-D″) Crb2a immunostaining in 96 hpf Tg(myl7:ras-EGFP) hearts treated between 54 and 96 hpf with DMSO (C-C″, n=14) or PD168393 (D-D″, n=19); arrowheads indicate Crb2a enrichment at the junctions between CMs. (E) Number of junctions between CMs with Crb2a enrichment. Each dot or square represents data from one heart. Data are mean±s.e.m. ****P<0.0001 by Student's t-test. (F) Crb2a immunostaining in 52 hpf Tg(myl7:ras-EGFP) embryos injected at the one-cell stage with a myocardial-specific nrg2a construct (myl7:nrg2a-p2a-tdTomato) (n=8). (F′,F″) Higher-magnification images show junctional localization of Crb2a in non-nrg2a-expressing CMs (arrowheads in white dashed box, F′) and apical Crb2a localization in nrg2a-expressing CMs (arrowheads in blue dashed box, F″). V, ventricle

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Development